Skip to content

Clinical trials

Stomach Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Country / region: Australia Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20081
20093
20102
20111
20125
20131
20143
20154
20164
20174
20187
20195
20207
20213
202215
20239
202412
202512
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Recruiting27
Active, not recruiting21
Terminated14
Unknown status5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen6
Bristol-Myers Squibb5
Hoffmann-La Roche5
AstraZeneca4
Novartis Pharmaceuticals4
BeiGene3
Eli Lilly and Company3
Merck Sharp & Dohme LLC3
Pfizer3
Arcus Biosciences, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms106
Carcinoma, Non-Small-Cell Lung34
Colorectal Neoplasms34
Ovarian Neoplasms29
Breast Neoplasms26
Esophageal Neoplasms23
Endometrial Neoplasms21
Pancreatic Neoplasms20
Melanoma19
Urinary Bladder Neoplasms18

Trials

Showing 76 to 100 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.